Skip to Content

Office of Research and Grant Development

Program Details

Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven Lung Cancers

Sponsor: Lung Cancer Research Foundation
Internal Deadline: 02/01/2024
Institutional Submission Limit: 1
Sponsor Deadline: 03/04/2024
Program Website

This competitive funding mechanism will provide up to $2,500,000 in funding over a four-year period. Proposals focused on the specific goal of curing oncogene-driven lung cancer should be submitted by teams of researchers with a program of closely integrated projects that would not otherwise be realized by a single component from the team. Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across the care continuum, with the immediate potential to increase survivorship. A clinical trial must either be initially incorporated into the project or be an immediate result of the outcome of the research.

   - USC will select 1 team to put forth the required LOI due to LCRF by March 4, 2024.
   - Based on LOIs, LCRF will invite selected Teams to submit full proposals.

NOTE: The Lung Cancer Research Foundation offers 5 different funding opportunities. Only the Team grant requires the limited submission internal review. However, applicants may only apply for one LCRF grant per grant cycle. For a listing of all 5 LCRF grants including eligibility criteria and application instructions, please review the LCRF webpage.


Submission Process

Limited submissions MUST be coordinated with the Office of the Vice President for Research.

If interested in applying for this opportunity, email a single PDF containing 1) a one to two-page project summary that includes addressing your plans/interest in forming a team (at top of first page provide the project title, PI, and list of key collaborators) and 2) a 2-3 page CV/biosketch for the PI (SCiENcv preferred) by 5pm on the INTERNAL DEADLINE above to Beth Herron at

Office of Research and Grant Development

    Challenge the conventional. Create the exceptional. No Limits.